Results 251 to 260 of about 94,347 (282)

Non‐Operable Squamous Cell Carcinoma of the Infraorbital Region Treated With Electrochemotherapy: A Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Cutaneous squamous cell carcinoma (cSCC) is a malignant epithelial tumor of the skin, classified as a nonmelanoma skin cancer. It may develop from precancerous conditions such as chronic inflammatory dermatoses, actinic keratosis, or actinic cheilitis, but can also arise de novo.
Gianluca Nicolai, Francesco Campanella, Sergio Alexandre Gehrke, Antonio Scarano   +3 more
wiley   +1 more source

Distinct tumor immune microenvironment modulation by anti-PD-1/PD-L1, VEGF, and CTLA-4 blockade provides a rationale for triplet therapy in hepatocellular carcinoma. [PDF]

Clin Mol Hepatol
Iwamoto H, Koga H, Kawaguchi T.
europepmc   +1 more source

Immune Checkpoint Dysregulation in Autoimmune Disorders: A Narrative Review of Therapeutic Implications. [PDF]

Cureus
Khan DM, Kumar R, Sriharsha M, Mahavadi S, Kishore A.   +4 more
europepmc   +1 more source

Multiple or Single Endocrine Abnormalities Associated With Immune Checkpoint Inhibitors.

J Clin Endocrinol Metab
Kamitani F, Nishioka Y, Nakajima H, Kurematsu Y, Okada S, Myojin T, Noda T, Imamura T, Takahashi Y.   +8 more
europepmc   +1 more source

Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer. [PDF]

J Immunother Cancer
Porter R, Bockorny B, Corr BR, Mahadevan D, Wilky BA, El-Khoueiry AB, Bullock AJ, Hafez N, Moser J, Martynova A, Stebbing J, Joshi B, Bourdelais S, Delepine C, Chand D, Wu W, Johnson B, Grossman JE, O'Day SJ, Matulonis UA, Gordon MS.   +20 more
europepmc   +1 more source

Advances in PD-1 and CTLA-4 dual-target immunotherapy for ovarian cancer. [PDF]

Front Immunol
Li DM, Pei KG, Yu XZ, Qie MR, Zhong L, Song L.   +5 more
europepmc   +1 more source

Analysis of the TCRβ repertoire characteristics when combining radiotherapy and immunotherapy in cancer. [PDF]

Oncol Lett
Yang X, Wei W, Feng Z, Zhang B, Liu Y, Yang F, Zhang C, Ou M, Liao S, Hou X.   +9 more
europepmc   +1 more source

Beyond monotherapy: multimodal strategies integrating immune checkpoint inhibitors in lymphoma management. [PDF]

Front Immunol
Li Y, Zheng R, Pan B, Wang X, Zhang L, Gao H, Li L.   +6 more
europepmc   +1 more source